Actos Defense Verdict In Maryland Upheld On Appeal
January 29, 2015
In an unreported decision of the Court of Special Appeals of Maryland dated December 4, 2014, the Court upheld a defense verdict in favor of the manufacturer of Actos, a FDA-approved prescription medication used to treat type 2 diabetes, in a lawsuit filed on behalf of the estate of a man who died[...]
Continue Reading
Maryland Actos Trial Underway
September 6, 2013
On September 3, 2013, a Baltimore City jury trial began in which the plaintiff alleges that the diabetes drug Actos was the cause of the bladder cancer that led to the death of a former U.S. Army translator in 2012. Actos is manufactured by Asia’s largest pharmaceutical manufacturer, Takeda P[...]
Continue Reading
